drugset / Trial / NCT04888728

To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers

NCT04888728

Phase 1 Completed 24 enrolled Daewoong Pharmaceutical Co. LTD.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

An open label, 2-part, one-sequence, 3-period study to evaluate drug-drug interactions between DWN12088 and nebivolol or Paroxetine in healthy volunteers

Timeline

Start
2021-06-30
Primary completion
2021-07-12
Completion
2021-07-27

Drugs

EvaluationDrugModalityDoseRoute
Subject BERSIPOROCIN Small molecule Oral
Subject Nebivolol Other / unclassified Oral
Subject Paroxetine Small molecule Oral